Antigen-Antibody Interaction and Clinical Immunology Guide to Immunologic Assays

Basis of Antigen-Antibody Binding

• Biomolecular Association: The interaction between an antigen (Ag) and an antibody (Ab) is a biomolecular association similar to an enzyme-substrate interaction.

• Key Distinctions from Enzyme-Substrate Interactions: Unlike many enzymatic reactions, the Ag-Ab interaction does not lead to an irreversible chemical alteration in either the antigen or the antibody molecule.

• Non-Covalent Nature: The binding involves various non-covalent interactions, including:

  • Hydrogen bonds

  • Ionic bonds

  • Hydrophobic interactions

  • Van der Waals forces

• High Specificity: The interaction is characterized by a very specific fit, a property that has enabled the development of numerous immunologic assays.

• Immune Complexes: When antigens and antibodies bind, they form immune complexes ($\text{Ag-Ab Complexes}$). The structure of an antibody involves specific regions:

  • Fab Region: The fragment antigen-binding region, containing the binding site.

  • Fc Region: The fragment crystallizable region, which interacts with cell surface receptors and complement proteins.

  • Hinge Region: The flexible part of the antibody that allows the Fab arms to move.

  • Variable ($V_H$, $V_L$) and Constant ($C_H$, $C_L$) Domains: Crucial for determining specificity and effector function.

  • Disulfide Bonds ($-SS-$): These stabilize the heavy and light chain interactions.

Quantitative Measures of Binding Strength: Affinity, Avidity, and Specificity

• Antibody Affinity:

  • Definition: A quantitative measure of the combined strength of the non-covalent interactions between a single antigen-binding site on an antibody and a single epitope.

  • Summary: It refers to the strength of a single antibody-antigen interaction. For example, each IgG antigen-binding site typically possesses high affinity for its target.

• Antibody Avidity:

  • Definition: The incorporate strength of multiple interactions between a multivalent antigen and an antibody.

  • Mechanism: When an IgG antibody binds a ligand with multiple identical epitopes, both binding sites can bind the same molecule.

  • Magnitude: Avidity is greater than affinity because both binding sites must dissociate simultaneously for the antibody to release the antigen.

  • Comparative Example: IgM typically has low-affinity antigen binding sites. However, since it is a pentamer with ten binding sites, its total avidity is very high.

• Specificity:

  • Definition: The ability of an individual antibody combining site to react with only one antigenic determinant (epitope).

  • Distinguishing Capabilities: Antibodies are highly specific and can distinguish differences in:

    • Primary structure of an antigen.

    • Isomeric forms of an antigen.

    • Secondary and tertiary structures of an antigen.

• Cross-Reactivity:

  • This occurs when an antibody elicited by one antigen reacts with an unrelated antigen.

  • Cause: This happens if two different antigens share an identical or very similar epitope.

Factors Affecting Antigen-Antibody Reactions

• Temperature:

  • The optimum temperature depends on the chemical nature of the epitope, the paratope, and the type of bonds involved.

  • Exothermic Interactions: Hydrogen bond formation is typically exothermic (\Delta H < 0). These bonds are more stable at lower temperatures and are particularly important when interacting with carbohydrate antigens.

• pH:

  • The equilibrium constant of the Ag-Ab complex is stable within the pH range of $6.5$ and $8.4$.

  • Inhibition: Reactions are strongly inhibited below pH $6.5$ and above pH $8.4$.

  • Sensitivity: At pH $5.0$ or $9.5$, the equilibrium constant is $100$-fold lower than it is at pH $6.5$ to $7.0$.

  • Conformational Changes: Extreme pH levels can induce conformational changes in antibodies that destroy complementarity with the antigen.

• Ionic Strength:

  • This is especially critical in blood group serology and is influenced by sodium ($Na^+$) and chloride ($Cl^-$) ions.

  • Charge Neutralization: In normal saline, ions cluster around the complex and partially neutralize charges, which can interfere with binding, particularly for low-affinity antibodies.

  • Sedimentation: At very low ionic strengths, $\gamma-globulins$ may aggregate and form reversible complexes with red blood cell lipoproteins, leading to sedimentation.

Fc Receptors ($FcR$) and Effector Functions

• Fc Receptor Overview: Receptors on effector cells (like macrophages or NK cells) recognize the Fc portion of antibodies bound to pathogens.

• Functional Outcomes:

  • Antibody-Dependent Cellular Phagocytosis (ADCP): Triggered by activating receptors, leading to the ingestion of the pathogen.

  • Antibody-Dependent Cellular Cytotoxicity (ADCC): NK cells use $CD16$ ($Fc\gamma RIIIA$) to recognize cell-bound antibodies. Cross-linking of $CD16$ triggers degranulation (release of lytic granules), causing target cell (e.g., tumor cell) death by apoptosis.

• Specific Human Fc receptors:

  • $Fc\gamma RI$ ($CD64$): Activating; High affinity; Distributed on macrophages, monocytes, neutrophils, DCs, and mast cells. Functions in ADCP and cytokine release.

  • $Fc\gamma RIIa$ ($CD32A$): Activating; Low affinity; Distributed on macrophages, monocytes, and various granulocytes. Functions in ADCC and ADCP.

  • $Fc\gamma RIIb$ ($CD32B$): Inhibitory (contains ITIM); Low affinity; Distributed on B cells and myeloid cells. Inhibits ADCC, ADCP, and B cell activation.

  • $Fc\gamma RIIc$ ($CD32C$): Activating; Low affinity; Enhances ADCC and ADCP.

  • $Fc\gamma RIIIa$ ($CD16A$): Activating; Low affinity; Found on NK cells and monocytes. Primary mediator of ADCC.

  • $Fc\gamma RIIIb$ ($CD16B$): Activating; Low affinity; Found on neutrophils. Acts as a decoy receptor that inhibits ADCP.

Clinical Implications and Immune Complex Disease

• Inflammation Induction: Immune complexes trigger inflammation by ligating Fc receptors, Complement ($C3$), or anaphylatoxin receptors (such as $C5a$) on mast cells and leukocytes (neutrophils).

• Immune-Complex Disease: A state where circulating complexes of coexisting immune reactants induce tissue injury.

• Case Study: COVID-19 Severity:

  • Antibody levels are associated with COVID-19 severity. High IgG and particularly high IgA levels correlate with intubated and deceased patients.

  • NETosis: High anti-spike IgA levels correlate with high levels of Neutrophil Extracellular Traps (NETs). IgA-Virus immune complexes are potent inducers of NETosis.

  • Severe COVID-19 Characteristics: Neutrophilia (immature neutrophils), increased circulating NETs, and high inflammation/coagulation markers.

Therapeutic Targeting in Immunopathology

• Fostamatinib:

  • An FDA-approved spleen tyrosine kinase ($SYK$) inhibitor (originally for thrombocytopenia).

  • Mechanism: It is a prodrug with an active metabolite, $R406$, which inhibits Fc-activating receptors and B-cell receptors.

  • Research Findings: In severe COVID-19, plasma from patients induces significant NET formation (DNA release) from neutrophils. Fostamatinib has been shown to inhibit this NET formation.

  • Clinical Trial Results: A randomized trial in hospitalized COVID-19 patients showed that Fostamatinib was safe, reduced serious adverse events ($10.5\%$ vs $22\%$ for placebo), and improved clinical outcomes (reduced ICU length of stay and days on oxygen).

Diagnostic Applications of Ag-Ab Interactions

• Antibody Titer vs. Concentration:

  • Concentration: The total protein amount in solution (e.g., $mg/dL$) regardless of function.

  • Titer: The functional concentration or highest dilution factor of a stock solution that still yields a measurable response in an immunoassay (e.g., $1/128$).

• Assay Examples:

  • ELISA: Used for serology (e.g., IgM testing).

  • Western Blot: Separates proteins by size (electrophoresis), transfers to a membrane, and uses antibodies for detection.

  • Flow Cytometry: Automated analysis/sorting of cells stained with fluorescent antibodies. Uses lasers to count intact cells in suspension. Vital for transplant medicine and identifying white blood cell types using markers like $CD45$ (Leukocytes) or $CD3$ (T cells).

  • Immunohistochemistry (IHC) and Immunofluorescence (IF): IHC uses colored chromogens (brightfield microscopy); IF uses fluorochromes (fluorescence microscopy).

• Monoclonal Antibody Therapy: Synthetic antibodies designed to lock onto specific antigens (e.g., on cancer cells) to trigger immune system attacks.

Questions & Discussion

Question 1: Pharmaceutical Monoclonal Antibody Mutations

• Prompt: A company introduces mutations to an antibody to improve interaction with a target epitope. Findings show the antibody remains bound for a prolonged duration even with competing molecules. What happened?

• Correct Answer: A. Increased affinity

• Reasoning: Affinity measures the strength of the interaction at a single binding site. Improving the interaction specifically at the epitope-binding site and increasing the residence time (binding duration) indicates higher affinity.

Question 2: Dengue vs. Zika Serology

• Prompt: A patient from Puerto Rico has fever, headache, and maculopapular rash. Dengue IgM ELISA is positive, but RT-PCR for dengue is negative. The physician suspects Zika. Why is the dengue test positive?

• Correct Answer: A) Cross-reactivity between dengue and Zika virus antibodies

• Reasoning: These viruses are closely related. If they share similar epitopes, antibodies produced against Zika may bind to the antigens used in the Dengue ELISA test, leading to a false positive for Dengue.

Question 3: High Avidity Comparison

• Prompt: Which antibody class has the higher avidity?

• Options: IgG, IgE, IgD, IgA, IgM.

• Correct Answer: E. IgM

• Reasoning: Since IgM is a pentamer with 10 antigen-binding sites, its cumulative binding strength (avidity) is significantly higher than monomeric or dimeric versions of other classes.

Question 4: Flow Cytometry Interpretation

• Prompt: A 6-year-old with recurrent fevers and splenomegaly has flow cytometry of NK cells and Th cells. The graph shows the patient's NK cell fluorescence is shifted to the left compared to the control.

• Correct Answer: C. Reduced perforin expression in NK, consistent with a perforin deficiency

• Reasoning: A leftward shift on a fluorescence histogram indicates lower expression of the target protein (perforin) within that specific cell population (NK cells) compared to the healthy control.**